Susquehanna International Group, LLP Rezolute, Inc. Transaction History
Susquehanna International Group, LLP
- $568 Billion
- Q1 2025
A detailed history of Susquehanna International Group, LLP transactions in Rezolute, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 926,657 shares of RZLT stock, worth $3.81 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
926,657
Previous 893,601
3.7%
Holding current value
$3.81 Million
Previous $4.26 Million
36.95%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding RZLT
# of Institutions
82Shares Held
39.7MCall Options Held
402KPut Options Held
19.4K-
Federated Hermes, Inc. Pittsburgh, PA11.3MShares$46.4 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$9.76 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.11MShares$8.68 Million1.66% of portfolio
-
Marshall Wace, LLP London, X01.85MShares$7.58 Million0.01% of portfolio
-
Blackstone Inc New York, NY1.74MShares$7.17 Million0.02% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $160M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...